ArticleMediterranean journal of hematology and infectious diseases2025
Efficacy and Safety of Teclistamab Followed by Autologous Stem Cell Transplant in Functional High-risk and Triple-class Refractory Multiple Myeloma.
Vincenzo Sammartano et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.